Hypouricemic effectiveness of synbiotic in the complex treatment in gout patients

Abstract

Objective — to evaluate the hypouricemic effects of the combination of synbiotic and allopurinol versus monotherapy with allopurinol in gout patients. Materials and methods. The examinations involved 130 patients (mean age (55.5 ± 9.4) years old) with gout (mean duration (7.7 ± 7.1) years). The gout diagnosis was based on the ACR criteria (2016). The control group consisted of 25 practically healthy men of the corresponding age. Patients with gout who have not reached the target uricemia level after 6 weeks of treatment with allopurinol were included in the treatment groups. The main group (n = 68) included patients who continued to take allopurinol in a dose of 300 mg per day with up-titration of 100 mg per month, and additionally took the synbiotic 1 capsule three times a day. The comparison group (n = 62) consisted of patients receiving allopurinol monotherapy. The treatment duration was 3 months. Qualitative and quantitative parameters of intestinal microbiote were analysed based on the data of bacteriological inoculation of faeces. The effectiveness of therapy was assessed by the levels of uricemia, C-RP, and the degree of dysbiotic changes in the intestinal microbiocenosis. Results and discussion. After treatment of patients in the main group with synbiotic using, the normalization of the indicators was observed due to the reduction of the concentration of opportunistic microorganisms of the Firmicutes group, obligate anaerobes, Bacteroides spp., Candida and the restoration of protective microflora — lacto- and bifidobacteria. In patients with gout after 3 months of complex treatment with the addition of a synbiotic, the transformation of the structure of the intestinal microbiota in the direction of normalization of qualitative (prevalence of mild degree of violations of microbiota in 50 % of subjects) and quantitative composition, revealed a more pronounced hypouricemic effect relative to the comparison group — the target level of uricemia is achieved twice as often — in 40.3 and 21 % of cases respectively. The additional inclusion of the synbiotic demonstrated an increase in the hypouricemic effect of allopurinol (a decrease in uric acid levels by 18.7 versus 13.3 %, p < 0.01), which was associated with more pronounced anti-inflammatory effect (a decrease in C-RP by 75 versus 26.3 %, p < 0.01). Conclusions. For patients with gout there is a pronounced violation of intestinal microbiota characterized by a combination of deficiency of protective microflora and an increase in obligate anaerobes, gram-positive cocci and fungi of the genus Candida. In patients with gout after 3 months of complex treatment with the addition of a synbiotic, against the background of the normalization of the qualitative and quantitative composition of intestinal microbiota, there is a more pronounced hypouricemic effect — the target level of uricemia is achieved twice as often, which is combined with more pronounced anti-inflammatory effect.

Authors and Affiliations

V. Е. Kondratiuk, O. M. Tarasenko, L. V. Natrus, I. G. Ponomarova

Keywords

Related Articles

Idiopathic inflammatory myopathies: difficulties of diagnosis

The rapid development of basic researches in medicine in the last decade allowed a new approach to the etiopathogenesis of a number of diseases, which, in particular, include inflammatory myopathies. Idiopathic inflammat...

The ultrasonographic and pathomorphological markers of liver steatosis in patients with non-alcoholic fatty liver disease depending on the presence of comorbid chronic kidney disease (chronic pyelonephritis) and obesity

Objective — to establish the peculiarities of ultrasonographic and pathomorphological changes of liver parenchyma in patients with non-alcoholic liver steatosis (NAS) and non-alcoholic steatohepatitis (NASH) depending o...

Morphology of glomerulonephritis in rheumatoid arthritis and comparison of clinical and laboratory characteristics

Objective — to determine the lifetime nature of the renal structures lesion and frequency of immune complex deposits in patients with mesangial glomerulonephritis in various clinical and laboratory variants of rheumatoid...

Platelet and coagulation hemostasis in conditions of the combined cardiac and gallbladder disorders

The changes in cardiac function resulting from the gallbladder (GB) disorders are known as a cholecystocardial syndrome. The complexity of its pathogenesis can be explained by simultaneous effects of several mechanisms (...

The mebicar efficacy in correction of the psycho-emotional background in patients with stable ischemic heart disease with permanent atrial fibrillation

Objective — to assess the dynamics of the psycho-emotional background under the influence of adminitrsation of the anxiolytic drug mebicar. Materials and methods. The observations were performed in 31 patients with stabl...

Download PDF file
  • EP ID EP587930
  • DOI 10.30978/UTJ2019-1-75
  • Views 91
  • Downloads 0

How To Cite

V. Е. Kondratiuk, O. M. Tarasenko, L. V. Natrus, I. G. Ponomarova (2019). Hypouricemic effectiveness of synbiotic in the complex treatment in gout patients. Український терапевтичний журнал, 0(1), 75-84. https://europub.co.uk/articles/-A-587930